Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald C Reed

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|June 17, 2006
Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER?Ronald C Reed, Sandeep Dutta
Journal of Clinical Pharmacology|July 21, 2006
A multiphasic absorption model best characterizes gastrointestinal absorption of divalproex sodium extended-release tabletsSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|May 26, 2007
What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen? : Examinations and Answers via Computer SimulationsRonald C Reed, Sandeep Dutta
Epilepsy Research|January 9, 2007
Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United StatesSandeep Dutta, Ronald C Reed
Epilepsy & Behavior : E&B|March 1, 2003
Comparison of lamotrigine and valproate with respect to quality of lifeRonald C Reed, Suzanne Giordano
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodiumRonald C Reed, Sandeep Dutta
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2006
Predicted plasma valproic acid concentrations in patients missing and replacing a full daily dose of extended-release divalproex sodiumSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|May 26, 2007
Divalproex to divalproex extended release conversionSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|February 6, 2007
Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ERSandeep Dutta, Ronald C Reed
Epilepsy & Behavior : E&B|December 17, 2022
Brivaracetam or levetiracetam in status epilepticus?: Lessons from the photosensitivity modelDorothee Kasteleijn-Nolst Trenite, Ronald C Reed
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|June 17, 2006
Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER?Ronald C Reed, Sandeep Dutta
Journal of Clinical Pharmacology|July 21, 2006
A multiphasic absorption model best characterizes gastrointestinal absorption of divalproex sodium extended-release tabletsSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|May 26, 2007
What Is the Best Strategy for Converting from Twice-Daily Divalproex to a Once-Daily Divalproex ER Regimen? : Examinations and Answers via Computer SimulationsRonald C Reed, Sandeep Dutta
Epilepsy Research|January 9, 2007
Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United StatesSandeep Dutta, Ronald C Reed
Epilepsy & Behavior : E&B|March 1, 2003
Comparison of lamotrigine and valproate with respect to quality of lifeRonald C Reed, Suzanne Giordano
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodiumRonald C Reed, Sandeep Dutta
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2006
Predicted plasma valproic acid concentrations in patients missing and replacing a full daily dose of extended-release divalproex sodiumSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|May 26, 2007
Divalproex to divalproex extended release conversionSandeep Dutta, Ronald C Reed
Clinical Drug Investigation|February 6, 2007
Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ERSandeep Dutta, Ronald C Reed
Epilepsy & Behavior : E&B|December 17, 2022
Brivaracetam or levetiracetam in status epilepticus?: Lessons from the photosensitivity modelDorothee Kasteleijn-Nolst Trenite, Ronald C Reed
Pageof 3